P13807 (GYS1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 134.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Glycogen [starch] synthase, muscle EC=2.4.1.11 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 737 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan. |
| Catalytic activity | UDP-glucose ((1->4)-alpha-D-glucosyl)(n) = UDP + ((1->4)-alpha-D-glucosyl)(n+1). |
| Enzyme regulation | Allosteric activation by glucose-6-phosphate. Phosphorylation reduces the activity towards UDP-glucose. When in the non-phosphorylated state, glycogen synthase does not require glucose-6-phosphate as an allosteric activator; when phosphorylated it does By similarity. |
| Pathway | |
| Subunit structure | Interacts with GYG1. Ref.8 |
| Post-translational modification | Phosphorylation at Ser-8 by AMPK inactivates the enzyme activity. Primed phosphorylation at Ser-657 (site 5) by CSNK2A1 and CSNK2A2 is required for inhibitory phosphorylation at Ser-641 (site 3a), Ser-645 (site 3b), Ser-649 (site 3c) and Ser-653 (site 4) by GSK3A an GSK3B By similarity. Phosphorylated at Ser-641 by DYRK2, leading to inactivation By similarity. Phosphorylated at Ser-641 by PASK, leading to inactivation; phosphorylation by PASK is inhibited by glycogen. Dephosphorylation at Ser-641 and Ser-645 by PP1 activates the enzyme. Ref.7 Ref.14 |
| Involvement in disease | Muscle glycogen storage disease 0 (GSD0b) [MIM:611556]: Metabolic disorder characterized by fasting hypoglycemia presenting in infancy or early childhood. The role of muscle glycogen is to provide critical energy during bursts of activity and sustained muscle work. |
| Sequence similarities | Belongs to the glycosyltransferase 3 family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Glycogen biosynthesis |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Disease | Diabetes mellitus Disease mutation |
| Molecular function | Glycosyltransferase Transferase |
| PTM | Phosphoprotein |
| Technical term | Allosteric enzyme Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | glucose metabolic process Traceable author statement. Source: Reactome glycogen biosynthetic processInferred from direct assay Ref.7. Source: UniProtKB heart developmentInferred from electronic annotation. Source: Compara small molecule metabolic processTraceable author statement. Source: Reactome |
| Cellular_component | cytosol Traceable author statement. Source: Reactome inclusion bodyInferred from electronic annotation. Source: Compara |
| Molecular_function | glucose binding Inferred from electronic annotation. Source: Compara glycogen (starch) synthase activityInferred from direct assay Ref.7. Source: UniProtKB |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| GYG1 | P46976 | 4 | EBI-740553,EBI-740533 |
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: P13807-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: P13807-2) The sequence of this isoform differs from the canonical sequence as follows: 101-164: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed By similarity | ||||||
| Chain | 2 – 737 | 736 | Glycogen [starch] synthase, muscle | PRO_0000194763 | |||||
Sites | |||||||||
| Binding site | 39 | 1 | UDP-glucose By similarity | ||||||
Amino acid modifications | |||||||||
| Modified residue | 8 | 1 | Phosphoserine; by AMPK and PKA By similarity | ||||||
| Modified residue | 11 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 641 | 1 | Phosphoserine Ref.7 Ref.11 Ref.14 | ||||||
| Modified residue | 645 | 1 | Phosphoserine Ref.11 Ref.14 | ||||||
| Modified residue | 649 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 653 | 1 | Phosphoserine; by GSK3-alpha and GSK3-beta By similarity | ||||||
| Modified residue | 657 | 1 | Phosphoserine; by CK2 By similarity | ||||||
| Modified residue | 698 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 727 | 1 | Phosphoserine Ref.12 | ||||||
Natural variations | |||||||||
| Alternative sequence | 101 – 164 | 64 | Missing in isoform 2. | VSP_042745 | |||||
| Natural variant | 108 | 1 | I → M. Corresponds to variant rs5455 [ dbSNP | Ensembl ]. | VAR_037958 | |||||
| Natural variant | 130 | 1 | K → E. Corresponds to variant rs5456 [ dbSNP | Ensembl ]. | VAR_014727 | |||||
| Natural variant | 283 | 1 | N → S. Corresponds to variant rs5461 [ dbSNP | Ensembl ]. | VAR_014728 | |||||
| Natural variant | 359 | 1 | E → G. Corresponds to variant rs5465 [ dbSNP | Ensembl ]. | VAR_014729 | |||||
| Natural variant | 416 | 1 | M → V. Corresponds to variant rs5447 [ dbSNP | Ensembl ]. | VAR_014730 | |||||
| Natural variant | 464 | 1 | G → S in NIDDM. Ref.2 | VAR_007859 | |||||
| Natural variant | 619 | 1 | E → Q. Corresponds to variant rs5450 [ dbSNP | Ensembl ]. | VAR_014731 | |||||
| Natural variant | 691 | 1 | P → A. Corresponds to variant rs5453 [ dbSNP | Ensembl ]. | VAR_014732 | |||||
Experimental info | |||||||||
| Mutagenesis | 641 | 1 | S → A: Abolishes PASK-mediated phosphorylation. Ref.7 | ||||||
| Mutagenesis | 645 | 1 | S → A: Does not affect PASK-mediated phosphorylation. Ref.7 | ||||||
| Sequence conflict | 136 | 1 | T → I in AAA88046. Ref.1 | ||||||
| Sequence conflict | 136 | 1 | T → I in AAB60385. Ref.3 | ||||||
| Sequence conflict | 462 | 1 | Missing in AAB60385. Ref.3 | ||||||
| Sequence conflict | 608 | 1 | A → D in AAB60385. Ref.3 | ||||||
| Sequence conflict | 706 | 1 | S → R in AAA88046. Ref.1 | ||||||
| Sequence conflict | 706 | 1 | S → R in AAB60385. Ref.3 | ||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Human muscle glycogen synthase cDNA sequence: a negatively charged protein with an asymmetric charge distribution." Browner M.F., Nakano K., Bang A.G., Fletterick R.J. Proc. Natl. Acad. Sci. U.S.A. 86:1443-1447(1989) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Muscle. |
| [2] | "Isolation and characterization of the human muscle glycogen synthase gene." Orho M., Nikula-Ijas P., Schalin-Jantti C., Permutt M.A., Groop L.C. Diabetes 44:1099-1105(1995) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT NIDDM SER-464. |
| [3] | "Cloning and characterization of a glycogen synthase cDNA from human endometrium." Su X., Schuler L., Shapiro S.S. J. Steroid Biochem. Mol. Biol. 59:459-465(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Endometrium. |
| [4] | "The DNA sequence and biology of human chromosome 19." Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., Carrano A.V. Lucas S.M.Nature 428:529-535(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). Tissue: Kidney, Lymph and Skin. |
| [7] | "Control of mammalian glycogen synthase by PAS kinase." Wilson W.A., Skurat A.V., Probst B., de Paoli-Roach A., Roach P.J., Rutter J. Proc. Natl. Acad. Sci. U.S.A. 102:16596-16601(2005) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION AT SER-641, MUTAGENESIS OF SER-641 AND SER-645. |
| [8] | "Interaction between glycogenin and glycogen synthase." Skurat A.V., Dietrich A.D., Roach P.J. Arch. Biochem. Biophys. 456:93-97(2006) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH GYG1. |
| [9] | "Cardiomyopathy and exercise intolerance in muscle glycogen storage disease 0." Kollberg G., Tulinius M., Gilljam T., Oestman-Smith I., Forsander G., Jotorp P., Oldfors A., Holme E. N. Engl. J. Med. 357:1507-1514(2007) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN GSD0B. |
| [10] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [11] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-641; SER-645 AND SER-649, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-727, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [13] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [14] | "R3F, a novel membrane-associated glycogen targeting subunit of protein phosphatase 1 regulates glycogen synthase in astrocytoma cells in response to glucose and extracellular signals." Kelsall I.R., Voss M., Munro S., Cuthbertson D.J., Cohen P.T. J. Neurochem. 118:596-610(2011) [PubMed] [Europe PMC] [Abstract] Cited for: DEPHOSPHORYLATION AT SER-641 AND SER-645 BY PP1. |
| [15] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | J04501 mRNA. Translation: AAA88046.1. Z33622 Z33633 Genomic DNA. Translation: CAA83916.1.U32573 mRNA. Translation: AAB60385.1. AC008687 Genomic DNA. No translation available. AC026803 Genomic DNA. No translation available. AC098792 Genomic DNA. No translation available. CH471177 Genomic DNA. Translation: EAW52424.1. BC002617 mRNA. Translation: AAH02617.1. BC003182 mRNA. Translation: AAH03182.1. BC007688 mRNA. Translation: AAH07688.1. |
| IPI | IPI00157144. IPI00303868. |
| PIR | A32156. |
| RefSeq | NP_001155059.1. NM_001161587.1. NP_002094.2. NM_002103.4. |
| UniGene | Hs.386225. |
3D structure databases | |
| ProteinModelPortal | P13807. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | P13807. 16 interactions. |
| STRING | 9606.ENSP00000317904. |
Protein family/group databases | |
| CAZy | GT3. Glycosyltransferase Family 3. |
PTM databases | |
| PhosphoSite | P13807. |
Polymorphism databases | |
| DMDM | 1351366. |
Proteomic databases | |
| PaxDb | P13807. |
| PRIDE | P13807. |
Protocols and materials databases | |
| DNASU | 2997. |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000263276; ENSP00000263276; ENSG00000104812. ENST00000323798; ENSP00000317904; ENSG00000104812. |
| GeneID | 2997. |
| KEGG | hsa:2997. |
| UCSC | uc002plp.3. human. |
Organism-specific databases | |
| CTD | 2997. |
| GeneCards | GC19M049471. |
| HGNC | HGNC:4706. GYS1. |
| HPA | CAB007793. |
| MIM | 138570. gene. 611556. phenotype. |
| neXtProt | NX_P13807. |
| Orphanet | 137625. Cardiomyopathy-exercise intolerance due to muscle and heart glycogen deficiency. |
| PharmGKB | PA29084. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0438. |
| HOGENOM | HOG000160890. |
| HOVERGEN | HBG001960. |
| InParanoid | P13807. |
| KO | K00693. |
| OMA | HEWLAGL. |
| OrthoDB | EOG4C2H91. |
| PhylomeDB | P13807. |
Enzyme and pathway databases | |
| BioCyc | MetaCyc:HS02622-MONOMER. |
| Pathway_Interaction_DB | insulin_glucose_pathway. Insulin-mediated glucose transport. |
| Reactome | REACT_111217. Metabolism. |
| UniPathway | UPA00164. |
Gene expression databases | |
| ArrayExpress | P13807. |
| Bgee | P13807. |
| CleanEx | HS_GYS1. |
| Genevestigator | P13807. |
| GermOnline | ENSG00000104812. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR008631. Glycogen_synth. [Graphical view] |
| PANTHER | PTHR10176. PTHR10176. 1 hit. |
| Pfam | PF05693. Glycogen_syn. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | P13807. |
| ChEMBL | CHEMBL4000. |
| ChiTaRS | GYS1. human. |
| GenomeRNAi | 2997. |
| NextBio | 11884. |
| SOURCE | Search... |
Entry information
| Entry name | GYS1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: P13807 Secondary accession number(s): Q9BTT9 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 19 Human chromosome 19: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PATHWAY comments Index of metabolic and biosynthesis pathways |
| SIMILARITY comments Index of protein domains and families |

Clusters with
